nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—UGT1A1—Naltrexone—alcohol dependence	0.551	1	CbGbCtD
Ezogabine—Dysphasia—Citalopram—alcohol dependence	0.00689	0.0367	CcSEcCtD
Ezogabine—KCNQ5—forebrain—alcohol dependence	0.00469	0.0495	CbGeAlD
Ezogabine—Chromaturia—Citalopram—alcohol dependence	0.00421	0.0225	CcSEcCtD
Ezogabine—Encephalopathy—Acamprosate—alcohol dependence	0.00391	0.0208	CcSEcCtD
Ezogabine—KCNQ3—forebrain—alcohol dependence	0.00377	0.0398	CbGeAlD
Ezogabine—Urinary hesitation—Citalopram—alcohol dependence	0.00367	0.0195	CcSEcCtD
Ezogabine—Psychotic disorder—Disulfiram—alcohol dependence	0.00361	0.0193	CcSEcCtD
Ezogabine—KCNQ2—brainstem—alcohol dependence	0.00359	0.0379	CbGeAlD
Ezogabine—KCNQ2—forebrain—alcohol dependence	0.00347	0.0366	CbGeAlD
Ezogabine—NAT2—endocrine gland—alcohol dependence	0.0032	0.0338	CbGeAlD
Ezogabine—KCNQ3—cardiovascular system—alcohol dependence	0.00319	0.0336	CbGeAlD
Ezogabine—Nephrolithiasis—Acamprosate—alcohol dependence	0.00312	0.0166	CcSEcCtD
Ezogabine—KCNQ5—midbrain—alcohol dependence	0.0031	0.0327	CbGeAlD
Ezogabine—UGT1A3—digestive system—alcohol dependence	0.00294	0.031	CbGeAlD
Ezogabine—NAT2—liver—alcohol dependence	0.00289	0.0305	CbGeAlD
Ezogabine—Balance disorder—Citalopram—alcohol dependence	0.00275	0.0147	CcSEcCtD
Ezogabine—Disturbance in attention—Naltrexone—alcohol dependence	0.00274	0.0146	CcSEcCtD
Ezogabine—KCNQ4—testis—alcohol dependence	0.00267	0.0282	CbGeAlD
Ezogabine—KCNQ2—gonad—alcohol dependence	0.00266	0.0281	CbGeAlD
Ezogabine—KCNQ5—nervous system—alcohol dependence	0.00255	0.0269	CbGeAlD
Ezogabine—Myoclonus—Citalopram—alcohol dependence	0.0025	0.0133	CcSEcCtD
Ezogabine—UGT1A4—digestive system—alcohol dependence	0.0025	0.0264	CbGeAlD
Ezogabine—KCNQ3—midbrain—alcohol dependence	0.00249	0.0263	CbGeAlD
Ezogabine—KCNQ4—cerebellum—alcohol dependence	0.00247	0.026	CbGeAlD
Ezogabine—KCNQ5—central nervous system—alcohol dependence	0.00245	0.0259	CbGeAlD
Ezogabine—UGT1A3—endocrine gland—alcohol dependence	0.00243	0.0256	CbGeAlD
Ezogabine—UGT1A4—blood—alcohol dependence	0.00238	0.0251	CbGeAlD
Ezogabine—Aphasia—Citalopram—alcohol dependence	0.00232	0.0124	CcSEcCtD
Ezogabine—Hypokinesia—Citalopram—alcohol dependence	0.00223	0.0119	CcSEcCtD
Ezogabine—UGT1A3—liver—alcohol dependence	0.00219	0.0231	CbGeAlD
Ezogabine—Nystagmus—Citalopram—alcohol dependence	0.00211	0.0112	CcSEcCtD
Ezogabine—UGT1A9—digestive system—alcohol dependence	0.00209	0.0221	CbGeAlD
Ezogabine—UGT1A4—endocrine gland—alcohol dependence	0.00206	0.0218	CbGeAlD
Ezogabine—KCNQ3—nervous system—alcohol dependence	0.00204	0.0216	CbGeAlD
Ezogabine—Euphoric mood—Naltrexone—alcohol dependence	0.00204	0.0109	CcSEcCtD
Ezogabine—KCNQ2—endocrine gland—alcohol dependence	0.00201	0.0212	CbGeAlD
Ezogabine—KCNQ4—brain—alcohol dependence	0.002	0.0211	CbGeAlD
Ezogabine—KCNQ3—central nervous system—alcohol dependence	0.00197	0.0208	CbGeAlD
Ezogabine—KCNQ5—brain—alcohol dependence	0.00195	0.0206	CbGeAlD
Ezogabine—Amnesia—Acamprosate—alcohol dependence	0.00194	0.0103	CcSEcCtD
Ezogabine—Increased appetite—Acamprosate—alcohol dependence	0.00194	0.0103	CcSEcCtD
Ezogabine—Disorientation—Naltrexone—alcohol dependence	0.00193	0.0103	CcSEcCtD
Ezogabine—KCNQ3—cerebellum—alcohol dependence	0.00192	0.0203	CbGeAlD
Ezogabine—KCNQ2—testis—alcohol dependence	0.00192	0.0202	CbGeAlD
Ezogabine—Memory impairment—Citalopram—alcohol dependence	0.00192	0.0102	CcSEcCtD
Ezogabine—KCNQ2—nervous system—alcohol dependence	0.00188	0.0199	CbGeAlD
Ezogabine—Nephrolithiasis—Citalopram—alcohol dependence	0.00187	0.00998	CcSEcCtD
Ezogabine—UGT1A4—liver—alcohol dependence	0.00186	0.0196	CbGeAlD
Ezogabine—Increased appetite—Naltrexone—alcohol dependence	0.00183	0.00978	CcSEcCtD
Ezogabine—Diplopia—Acamprosate—alcohol dependence	0.00182	0.00971	CcSEcCtD
Ezogabine—KCNQ2—central nervous system—alcohol dependence	0.00181	0.0191	CbGeAlD
Ezogabine—Psychotic disorder—Acamprosate—alcohol dependence	0.00178	0.00948	CcSEcCtD
Ezogabine—KCNQ2—cerebellum—alcohol dependence	0.00177	0.0187	CbGeAlD
Ezogabine—Disturbance in attention—Citalopram—alcohol dependence	0.00174	0.00926	CcSEcCtD
Ezogabine—UGT1A9—endocrine gland—alcohol dependence	0.00173	0.0183	CbGeAlD
Ezogabine—Psychotic disorder—Naltrexone—alcohol dependence	0.00168	0.00897	CcSEcCtD
Ezogabine—Liver function test abnormal—Acamprosate—alcohol dependence	0.00168	0.00896	CcSEcCtD
Ezogabine—Skin discolouration—Citalopram—alcohol dependence	0.00167	0.00888	CcSEcCtD
Ezogabine—Paraesthesia—Disulfiram—alcohol dependence	0.00163	0.0087	CcSEcCtD
Ezogabine—Somnolence—Disulfiram—alcohol dependence	0.00162	0.00861	CcSEcCtD
Ezogabine—Dysarthria—Citalopram—alcohol dependence	0.00159	0.00848	CcSEcCtD
Ezogabine—Influenza—Acamprosate—alcohol dependence	0.00157	0.00839	CcSEcCtD
Ezogabine—Dysphagia—Acamprosate—alcohol dependence	0.00157	0.00839	CcSEcCtD
Ezogabine—Fatigue—Disulfiram—alcohol dependence	0.00157	0.00835	CcSEcCtD
Ezogabine—KCNQ3—brain—alcohol dependence	0.00156	0.0165	CbGeAlD
Ezogabine—UGT1A9—liver—alcohol dependence	0.00156	0.0165	CbGeAlD
Ezogabine—Gait disturbance—Citalopram—alcohol dependence	0.00154	0.00822	CcSEcCtD
Ezogabine—Coordination abnormal—Citalopram—alcohol dependence	0.00153	0.00817	CcSEcCtD
Ezogabine—Influenza—Naltrexone—alcohol dependence	0.00149	0.00794	CcSEcCtD
Ezogabine—KCNQ2—brain—alcohol dependence	0.00144	0.0152	CbGeAlD
Ezogabine—UGT1A1—digestive system—alcohol dependence	0.00143	0.0151	CbGeAlD
Ezogabine—Weight increased—Acamprosate—alcohol dependence	0.00143	0.00764	CcSEcCtD
Ezogabine—Coma—Citalopram—alcohol dependence	0.00137	0.00733	CcSEcCtD
Ezogabine—UGT1A1—blood—alcohol dependence	0.00137	0.0144	CbGeAlD
Ezogabine—Weight increased—Naltrexone—alcohol dependence	0.00136	0.00723	CcSEcCtD
Ezogabine—Haematuria—Acamprosate—alcohol dependence	0.00134	0.00713	CcSEcCtD
Ezogabine—Infestation NOS—Naltrexone—alcohol dependence	0.00133	0.00708	CcSEcCtD
Ezogabine—Infestation—Naltrexone—alcohol dependence	0.00133	0.00708	CcSEcCtD
Ezogabine—Asthenia—Disulfiram—alcohol dependence	0.0013	0.00695	CcSEcCtD
Ezogabine—Euphoric mood—Citalopram—alcohol dependence	0.00129	0.00689	CcSEcCtD
Ezogabine—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00126	0.0067	CcSEcCtD
Ezogabine—Hallucination—Acamprosate—alcohol dependence	0.00125	0.00668	CcSEcCtD
Ezogabine—Oedema peripheral—Acamprosate—alcohol dependence	0.00124	0.00662	CcSEcCtD
Ezogabine—KCNQ2—Neuronal System—KCNJ6—alcohol dependence	0.00123	0.00736	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—KCNJ6—alcohol dependence	0.00123	0.00736	CbGpPWpGaD
Ezogabine—Disorientation—Citalopram—alcohol dependence	0.00122	0.00651	CcSEcCtD
Ezogabine—NAT2—Biological oxidations—ADH1B—alcohol dependence	0.00122	0.00731	CbGpPWpGaD
Ezogabine—Visual impairment—Acamprosate—alcohol dependence	0.00121	0.00647	CcSEcCtD
Ezogabine—Dizziness—Disulfiram—alcohol dependence	0.0012	0.00641	CcSEcCtD
Ezogabine—Hallucination—Naltrexone—alcohol dependence	0.00119	0.00632	CcSEcCtD
Ezogabine—UGT1A1—endocrine gland—alcohol dependence	0.00119	0.0125	CbGeAlD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00117	0.00703	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—ADH6—alcohol dependence	0.00117	0.00701	CbGpPWpGaD
Ezogabine—UGT1A4—Biological oxidations—ADH1A—alcohol dependence	0.00116	0.00699	CbGpPWpGaD
Ezogabine—Increased appetite—Citalopram—alcohol dependence	0.00116	0.0062	CcSEcCtD
Ezogabine—Amnesia—Citalopram—alcohol dependence	0.00116	0.0062	CcSEcCtD
Ezogabine—UGT1A3—Phase II conjugation—GGT2—alcohol dependence	0.00115	0.00688	CbGpPWpGaD
Ezogabine—Rash—Disulfiram—alcohol dependence	0.00115	0.00611	CcSEcCtD
Ezogabine—Eye disorder—Naltrexone—alcohol dependence	0.00111	0.00594	CcSEcCtD
Ezogabine—Alopecia—Acamprosate—alcohol dependence	0.00111	0.00594	CcSEcCtD
Ezogabine—Mental disorder—Acamprosate—alcohol dependence	0.0011	0.00588	CcSEcCtD
Ezogabine—Malnutrition—Acamprosate—alcohol dependence	0.0011	0.00585	CcSEcCtD
Ezogabine—Diplopia—Citalopram—alcohol dependence	0.00109	0.00582	CcSEcCtD
Ezogabine—Osteoarthritis—Citalopram—alcohol dependence	0.00109	0.00582	CcSEcCtD
Ezogabine—NAT2—Phase II conjugation—GGT1—alcohol dependence	0.00108	0.00646	CbGpPWpGaD
Ezogabine—UGT1A1—liver—alcohol dependence	0.00107	0.0113	CbGeAlD
Ezogabine—Psychotic disorder—Citalopram—alcohol dependence	0.00107	0.00568	CcSEcCtD
Ezogabine—Muscle spasms—Acamprosate—alcohol dependence	0.00105	0.00562	CcSEcCtD
Ezogabine—Alopecia—Naltrexone—alcohol dependence	0.00105	0.00562	CcSEcCtD
Ezogabine—Mental disorder—Naltrexone—alcohol dependence	0.00104	0.00557	CcSEcCtD
Ezogabine—Urinary retention—Citalopram—alcohol dependence	0.00104	0.00553	CcSEcCtD
Ezogabine—Malnutrition—Naltrexone—alcohol dependence	0.00104	0.00553	CcSEcCtD
Ezogabine—CYP2A6—Xenobiotics—CYP2E1—alcohol dependence	0.00103	0.00618	CbGpPWpGaD
Ezogabine—Tremor—Acamprosate—alcohol dependence	0.00103	0.00548	CcSEcCtD
Ezogabine—Ill-defined disorder—Acamprosate—alcohol dependence	0.00102	0.00543	CcSEcCtD
Ezogabine—KCNQ4—Neuronal System—ALDH2—alcohol dependence	0.00101	0.00609	CbGpPWpGaD
Ezogabine—KCNQ5—Neuronal System—ALDH2—alcohol dependence	0.00101	0.00609	CbGpPWpGaD
Ezogabine—NAT2—Biological oxidations—MAOB—alcohol dependence	0.00101	0.00606	CbGpPWpGaD
Ezogabine—Liver function test abnormal—Citalopram—alcohol dependence	0.00101	0.00537	CcSEcCtD
Ezogabine—Muscle spasms—Naltrexone—alcohol dependence	0.000998	0.00532	CcSEcCtD
Ezogabine—CYP2A6—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00099	0.00594	CbGpPWpGaD
Ezogabine—UGT1A4—Biological oxidations—ADH4—alcohol dependence	0.00099	0.00594	CbGpPWpGaD
Ezogabine—Malaise—Acamprosate—alcohol dependence	0.000989	0.00527	CcSEcCtD
Ezogabine—Vertigo—Acamprosate—alcohol dependence	0.000985	0.00525	CcSEcCtD
Ezogabine—Syncope—Acamprosate—alcohol dependence	0.000984	0.00524	CcSEcCtD
Ezogabine—Leukopenia—Acamprosate—alcohol dependence	0.000982	0.00523	CcSEcCtD
Ezogabine—Vision blurred—Naltrexone—alcohol dependence	0.000978	0.00521	CcSEcCtD
Ezogabine—Tremor—Naltrexone—alcohol dependence	0.000972	0.00518	CcSEcCtD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00097	0.00582	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—ADH1A—alcohol dependence	0.000968	0.00581	CbGpPWpGaD
Ezogabine—Loss of consciousness—Acamprosate—alcohol dependence	0.000964	0.00514	CcSEcCtD
Ezogabine—Ill-defined disorder—Naltrexone—alcohol dependence	0.000963	0.00513	CcSEcCtD
Ezogabine—UGT1A4—NRF2 pathway—ADH7—alcohol dependence	0.00096	0.00576	CbGpPWpGaD
Ezogabine—Dysphagia—Citalopram—alcohol dependence	0.000944	0.00503	CcSEcCtD
Ezogabine—Influenza—Citalopram—alcohol dependence	0.000944	0.00503	CcSEcCtD
Ezogabine—Malaise—Naltrexone—alcohol dependence	0.000936	0.00499	CcSEcCtD
Ezogabine—Syncope—Naltrexone—alcohol dependence	0.000931	0.00496	CcSEcCtD
Ezogabine—Anxiety—Acamprosate—alcohol dependence	0.000931	0.00496	CcSEcCtD
Ezogabine—Discomfort—Acamprosate—alcohol dependence	0.000923	0.00492	CcSEcCtD
Ezogabine—UGT1A4—NRF2 pathway—GGT2—alcohol dependence	0.00092	0.00552	CbGpPWpGaD
Ezogabine—Dry mouth—Acamprosate—alcohol dependence	0.000913	0.00487	CcSEcCtD
Ezogabine—Loss of consciousness—Naltrexone—alcohol dependence	0.000912	0.00486	CcSEcCtD
Ezogabine—Confusional state—Acamprosate—alcohol dependence	0.000903	0.00481	CcSEcCtD
Ezogabine—CYP2A6—liver—alcohol dependence	0.000901	0.00951	CbGeAlD
Ezogabine—Infection—Acamprosate—alcohol dependence	0.000889	0.00474	CcSEcCtD
Ezogabine—KCNQ2—Neuronal System—GABRB1—alcohol dependence	0.000887	0.00532	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—GABRB1—alcohol dependence	0.000887	0.00532	CbGpPWpGaD
Ezogabine—Dysuria—Citalopram—alcohol dependence	0.000882	0.0047	CcSEcCtD
Ezogabine—Shock—Acamprosate—alcohol dependence	0.000881	0.0047	CcSEcCtD
Ezogabine—Anxiety—Naltrexone—alcohol dependence	0.00088	0.00469	CcSEcCtD
Ezogabine—CYP2A6—cerebellum—alcohol dependence	0.00088	0.00929	CbGeAlD
Ezogabine—Thrombocytopenia—Acamprosate—alcohol dependence	0.000877	0.00467	CcSEcCtD
Ezogabine—Discomfort—Naltrexone—alcohol dependence	0.000873	0.00465	CcSEcCtD
Ezogabine—Hyperhidrosis—Acamprosate—alcohol dependence	0.000865	0.00461	CcSEcCtD
Ezogabine—Dry mouth—Naltrexone—alcohol dependence	0.000864	0.00461	CcSEcCtD
Ezogabine—Weight increased—Citalopram—alcohol dependence	0.000859	0.00458	CcSEcCtD
Ezogabine—NAT2—Biological oxidations—ALDH2—alcohol dependence	0.000858	0.00515	CbGpPWpGaD
Ezogabine—UGT1A1—NRF2 pathway—ALDH3A1—alcohol dependence	0.000855	0.00513	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—ALDH3A1—alcohol dependence	0.000855	0.00513	CbGpPWpGaD
Ezogabine—Confusional state—Naltrexone—alcohol dependence	0.000854	0.00455	CcSEcCtD
Ezogabine—UGT1A4—Biological oxidations—ADH7—alcohol dependence	0.000842	0.00505	CbGpPWpGaD
Ezogabine—Infection—Naltrexone—alcohol dependence	0.000841	0.00449	CcSEcCtD
Ezogabine—Infestation—Citalopram—alcohol dependence	0.000841	0.00449	CcSEcCtD
Ezogabine—Infestation NOS—Citalopram—alcohol dependence	0.000841	0.00449	CcSEcCtD
Ezogabine—Shock—Naltrexone—alcohol dependence	0.000833	0.00444	CcSEcCtD
Ezogabine—Nervous system disorder—Naltrexone—alcohol dependence	0.000831	0.00443	CcSEcCtD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000825	0.00495	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—ADH4—alcohol dependence	0.000823	0.00494	CbGpPWpGaD
Ezogabine—Hyperhidrosis—Naltrexone—alcohol dependence	0.000819	0.00436	CcSEcCtD
Ezogabine—UGT1A4—Biological oxidations—GGT2—alcohol dependence	0.000807	0.00484	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—ADH6—alcohol dependence	0.000807	0.00484	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—ADH6—alcohol dependence	0.000807	0.00484	CbGpPWpGaD
Ezogabine—Paraesthesia—Acamprosate—alcohol dependence	0.000804	0.00429	CcSEcCtD
Ezogabine—Haematuria—Citalopram—alcohol dependence	0.000802	0.00428	CcSEcCtD
Ezogabine—KCNQ5—Neuronal System—GRIN2B—alcohol dependence	0.000802	0.00481	CbGpPWpGaD
Ezogabine—KCNQ4—Neuronal System—GRIN2B—alcohol dependence	0.000802	0.00481	CbGpPWpGaD
Ezogabine—Dyspnoea—Acamprosate—alcohol dependence	0.000798	0.00425	CcSEcCtD
Ezogabine—UGT1A3—NRF2 pathway—ADH7—alcohol dependence	0.000798	0.00479	CbGpPWpGaD
Ezogabine—Somnolence—Acamprosate—alcohol dependence	0.000796	0.00424	CcSEcCtD
Ezogabine—Hepatobiliary disease—Citalopram—alcohol dependence	0.000796	0.00424	CcSEcCtD
Ezogabine—UGT1A1—Phase II conjugation—GGT2—alcohol dependence	0.000792	0.00475	CbGpPWpGaD
Ezogabine—UGT1A9—Phase II conjugation—GGT2—alcohol dependence	0.000792	0.00475	CbGpPWpGaD
Ezogabine—KCNQ4—Neuronal System—SLC6A3—alcohol dependence	0.000791	0.00474	CbGpPWpGaD
Ezogabine—KCNQ5—Neuronal System—SLC6A3—alcohol dependence	0.000791	0.00474	CbGpPWpGaD
Ezogabine—Dyspepsia—Acamprosate—alcohol dependence	0.000788	0.0042	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000773	0.00412	CcSEcCtD
Ezogabine—Constipation—Acamprosate—alcohol dependence	0.000766	0.00408	CcSEcCtD
Ezogabine—UGT1A3—NRF2 pathway—GGT2—alcohol dependence	0.000765	0.00459	CbGpPWpGaD
Ezogabine—Paraesthesia—Naltrexone—alcohol dependence	0.000761	0.00405	CcSEcCtD
Ezogabine—Dyspnoea—Naltrexone—alcohol dependence	0.000755	0.00403	CcSEcCtD
Ezogabine—KCNQ3—Neuronal System—GABRA2—alcohol dependence	0.000754	0.00453	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—GABRA2—alcohol dependence	0.000754	0.00453	CbGpPWpGaD
Ezogabine—Somnolence—Naltrexone—alcohol dependence	0.000753	0.00401	CcSEcCtD
Ezogabine—Hallucination—Citalopram—alcohol dependence	0.000752	0.00401	CcSEcCtD
Ezogabine—Urinary tract disorder—Citalopram—alcohol dependence	0.000746	0.00398	CcSEcCtD
Ezogabine—Oedema peripheral—Citalopram—alcohol dependence	0.000744	0.00397	CcSEcCtD
Ezogabine—Urethral disorder—Citalopram—alcohol dependence	0.00074	0.00395	CcSEcCtD
Ezogabine—UGT1A4—Biological oxidations—ADH1B—alcohol dependence	0.000738	0.00443	CbGpPWpGaD
Ezogabine—Feeling abnormal—Acamprosate—alcohol dependence	0.000738	0.00393	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000731	0.0039	CcSEcCtD
Ezogabine—Fatigue—Naltrexone—alcohol dependence	0.00073	0.00389	CcSEcCtD
Ezogabine—Visual impairment—Citalopram—alcohol dependence	0.000728	0.00388	CcSEcCtD
Ezogabine—Constipation—Naltrexone—alcohol dependence	0.000724	0.00386	CcSEcCtD
Ezogabine—CYP2A6—brain—alcohol dependence	0.000715	0.00754	CbGeAlD
Ezogabine—Eye disorder—Citalopram—alcohol dependence	0.000706	0.00376	CcSEcCtD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000701	0.00421	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—ADH7—alcohol dependence	0.0007	0.0042	CbGpPWpGaD
Ezogabine—Feeling abnormal—Naltrexone—alcohol dependence	0.000698	0.00372	CcSEcCtD
Ezogabine—NAT2—Biological oxidations—CYP2E1—alcohol dependence	0.000686	0.00412	CbGpPWpGaD
Ezogabine—NAT2—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000677	0.00406	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—GGT2—alcohol dependence	0.000671	0.00403	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—ADH1A—alcohol dependence	0.000669	0.00401	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—ADH1A—alcohol dependence	0.000669	0.00401	CbGpPWpGaD
Ezogabine—Alopecia—Citalopram—alcohol dependence	0.000667	0.00356	CcSEcCtD
Ezogabine—KCNQ5—Neuronal System—MAOA—alcohol dependence	0.000667	0.00401	CbGpPWpGaD
Ezogabine—KCNQ4—Neuronal System—MAOA—alcohol dependence	0.000667	0.00401	CbGpPWpGaD
Ezogabine—Mental disorder—Citalopram—alcohol dependence	0.000662	0.00353	CcSEcCtD
Ezogabine—CYP2A6—NRF2 pathway—ALDH3A1—alcohol dependence	0.000659	0.00396	CbGpPWpGaD
Ezogabine—Malnutrition—Citalopram—alcohol dependence	0.000658	0.00351	CcSEcCtD
Ezogabine—UGT1A4—Phase II conjugation—GGT1—alcohol dependence	0.000652	0.00391	CbGpPWpGaD
Ezogabine—Asthenia—Acamprosate—alcohol dependence	0.000642	0.00342	CcSEcCtD
Ezogabine—Muscle spasms—Citalopram—alcohol dependence	0.000632	0.00337	CcSEcCtD
Ezogabine—NAT2—Biological oxidations—GGT1—alcohol dependence	0.00063	0.00378	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—ADH6—alcohol dependence	0.000622	0.00373	CbGpPWpGaD
Ezogabine—Vision blurred—Citalopram—alcohol dependence	0.00062	0.0033	CcSEcCtD
Ezogabine—Tremor—Citalopram—alcohol dependence	0.000616	0.00328	CcSEcCtD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000615	0.00369	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—ADH1B—alcohol dependence	0.000613	0.00368	CbGpPWpGaD
Ezogabine—UGT1A4—Biological oxidations—MAOB—alcohol dependence	0.000611	0.00367	CbGpPWpGaD
Ezogabine—Ill-defined disorder—Citalopram—alcohol dependence	0.00061	0.00325	CcSEcCtD
Ezogabine—Asthenia—Naltrexone—alcohol dependence	0.000608	0.00324	CcSEcCtD
Ezogabine—Malaise—Citalopram—alcohol dependence	0.000593	0.00316	CcSEcCtD
Ezogabine—Dizziness—Acamprosate—alcohol dependence	0.000592	0.00316	CcSEcCtD
Ezogabine—Vertigo—Citalopram—alcohol dependence	0.000591	0.00315	CcSEcCtD
Ezogabine—Syncope—Citalopram—alcohol dependence	0.00059	0.00314	CcSEcCtD
Ezogabine—Leukopenia—Citalopram—alcohol dependence	0.000589	0.00314	CcSEcCtD
Ezogabine—Loss of consciousness—Citalopram—alcohol dependence	0.000578	0.00308	CcSEcCtD
Ezogabine—UGT1A1—Biological oxidations—ADH4—alcohol dependence	0.000568	0.00341	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—ADH4—alcohol dependence	0.000568	0.00341	CbGpPWpGaD
Ezogabine—NAT2—Biological oxidations—MAOA—alcohol dependence	0.000564	0.00339	CbGpPWpGaD
Ezogabine—Rash—Acamprosate—alcohol dependence	0.000564	0.00301	CcSEcCtD
Ezogabine—Dermatitis—Acamprosate—alcohol dependence	0.000564	0.00301	CcSEcCtD
Ezogabine—Dizziness—Naltrexone—alcohol dependence	0.00056	0.00299	CcSEcCtD
Ezogabine—Anxiety—Citalopram—alcohol dependence	0.000558	0.00297	CcSEcCtD
Ezogabine—Discomfort—Citalopram—alcohol dependence	0.000553	0.00295	CcSEcCtD
Ezogabine—UGT1A1—NRF2 pathway—ADH7—alcohol dependence	0.000551	0.00331	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—ADH7—alcohol dependence	0.000551	0.00331	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—ALDH2—alcohol dependence	0.000548	0.00329	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—ALDH2—alcohol dependence	0.000548	0.00329	CbGpPWpGaD
Ezogabine—Dry mouth—Citalopram—alcohol dependence	0.000548	0.00292	CcSEcCtD
Ezogabine—UGT1A3—Phase II conjugation—GGT1—alcohol dependence	0.000542	0.00325	CbGpPWpGaD
Ezogabine—Confusional state—Citalopram—alcohol dependence	0.000541	0.00288	CcSEcCtD
Ezogabine—Rash—Naltrexone—alcohol dependence	0.000534	0.00285	CcSEcCtD
Ezogabine—Dermatitis—Naltrexone—alcohol dependence	0.000534	0.00284	CcSEcCtD
Ezogabine—Infection—Citalopram—alcohol dependence	0.000533	0.00284	CcSEcCtD
Ezogabine—Nausea—Acamprosate—alcohol dependence	0.000532	0.00283	CcSEcCtD
Ezogabine—UGT1A1—NRF2 pathway—GGT2—alcohol dependence	0.000528	0.00317	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—GGT2—alcohol dependence	0.000528	0.00317	CbGpPWpGaD
Ezogabine—Shock—Citalopram—alcohol dependence	0.000528	0.00281	CcSEcCtD
Ezogabine—Nervous system disorder—Citalopram—alcohol dependence	0.000526	0.00281	CcSEcCtD
Ezogabine—Thrombocytopenia—Citalopram—alcohol dependence	0.000525	0.0028	CcSEcCtD
Ezogabine—UGT1A4—Biological oxidations—ALDH2—alcohol dependence	0.00052	0.00312	CbGpPWpGaD
Ezogabine—Hyperhidrosis—Citalopram—alcohol dependence	0.000519	0.00277	CcSEcCtD
Ezogabine—UGT1A4—NRF2 pathway—SLC6A4—alcohol dependence	0.000518	0.00311	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—ADH1A—alcohol dependence	0.000515	0.00309	CbGpPWpGaD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.00051	0.00306	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—MAOB—alcohol dependence	0.000508	0.00305	CbGpPWpGaD
Ezogabine—Nausea—Naltrexone—alcohol dependence	0.000503	0.00268	CcSEcCtD
Ezogabine—UGT1A1—Biological oxidations—ADH7—alcohol dependence	0.000483	0.0029	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—ADH7—alcohol dependence	0.000483	0.0029	CbGpPWpGaD
Ezogabine—Paraesthesia—Citalopram—alcohol dependence	0.000482	0.00257	CcSEcCtD
Ezogabine—Dyspnoea—Citalopram—alcohol dependence	0.000478	0.00255	CcSEcCtD
Ezogabine—Somnolence—Citalopram—alcohol dependence	0.000477	0.00254	CcSEcCtD
Ezogabine—Dyspepsia—Citalopram—alcohol dependence	0.000472	0.00252	CcSEcCtD
Ezogabine—UGT1A1—Biological oxidations—GGT2—alcohol dependence	0.000463	0.00278	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—GGT2—alcohol dependence	0.000463	0.00278	CbGpPWpGaD
Ezogabine—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000463	0.00247	CcSEcCtD
Ezogabine—Fatigue—Citalopram—alcohol dependence	0.000463	0.00247	CcSEcCtD
Ezogabine—UGT1A4—NRF2 pathway—SLC6A3—alcohol dependence	0.000462	0.00277	CbGpPWpGaD
Ezogabine—Constipation—Citalopram—alcohol dependence	0.000459	0.00245	CcSEcCtD
Ezogabine—Feeling abnormal—Citalopram—alcohol dependence	0.000442	0.00236	CcSEcCtD
Ezogabine—CYP2A6—Biological oxidations—ADH4—alcohol dependence	0.000438	0.00263	CbGpPWpGaD
Ezogabine—UGT1A4—NRF2 pathway—GGT1—alcohol dependence	0.000435	0.00261	CbGpPWpGaD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000433	0.0026	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—GRIN2B—alcohol dependence	0.000433	0.0026	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—GRIN2B—alcohol dependence	0.000433	0.0026	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—ALDH2—alcohol dependence	0.000432	0.00259	CbGpPWpGaD
Ezogabine—UGT1A3—NRF2 pathway—SLC6A4—alcohol dependence	0.000431	0.00258	CbGpPWpGaD
Ezogabine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000427	0.00256	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—SLC6A3—alcohol dependence	0.000427	0.00256	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—SLC6A3—alcohol dependence	0.000427	0.00256	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—ADH7—alcohol dependence	0.000425	0.00255	CbGpPWpGaD
Ezogabine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000424	0.00255	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—ADH1B—alcohol dependence	0.000424	0.00254	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—ADH1B—alcohol dependence	0.000424	0.00254	CbGpPWpGaD
Ezogabine—CYP2A6—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000422	0.00253	CbGpPWpGaD
Ezogabine—UGT1A4—Biological oxidations—CYP2E1—alcohol dependence	0.000416	0.00249	CbGpPWpGaD
Ezogabine—UGT1A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.00041	0.00246	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—GGT2—alcohol dependence	0.000407	0.00244	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ADH6—alcohol dependence	0.000397	0.00238	CbGpPWpGaD
Ezogabine—Asthenia—Citalopram—alcohol dependence	0.000385	0.00205	CcSEcCtD
Ezogabine—KCNQ2—Axon guidance—GRIN2B—alcohol dependence	0.000384	0.00231	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—GRIN2B—alcohol dependence	0.000384	0.00231	CbGpPWpGaD
Ezogabine—UGT1A3—NRF2 pathway—SLC6A3—alcohol dependence	0.000384	0.0023	CbGpPWpGaD
Ezogabine—UGT1A4—Biological oxidations—GGT1—alcohol dependence	0.000382	0.00229	CbGpPWpGaD
Ezogabine—UGT1A1—Phase II conjugation—GGT1—alcohol dependence	0.000375	0.00225	CbGpPWpGaD
Ezogabine—UGT1A9—Phase II conjugation—GGT1—alcohol dependence	0.000375	0.00225	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—ADH7—alcohol dependence	0.000373	0.00224	CbGpPWpGaD
Ezogabine—NAT2—Biological oxidations—POMC—alcohol dependence	0.000368	0.00221	CbGpPWpGaD
Ezogabine—UGT1A3—NRF2 pathway—GGT1—alcohol dependence	0.000362	0.00217	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—MAOA—alcohol dependence	0.00036	0.00216	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—MAOA—alcohol dependence	0.00036	0.00216	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—GGT2—alcohol dependence	0.000357	0.00214	CbGpPWpGaD
Ezogabine—Dizziness—Citalopram—alcohol dependence	0.000355	0.00189	CcSEcCtD
Ezogabine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000353	0.00212	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—MAOB—alcohol dependence	0.000351	0.00211	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—MAOB—alcohol dependence	0.000351	0.00211	CbGpPWpGaD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000346	0.00208	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—CYP2E1—alcohol dependence	0.000346	0.00207	CbGpPWpGaD
Ezogabine—UGT1A4—Biological oxidations—MAOA—alcohol dependence	0.000342	0.00205	CbGpPWpGaD
Ezogabine—UGT1A3—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000341	0.00205	CbGpPWpGaD
Ezogabine—Rash—Citalopram—alcohol dependence	0.000338	0.0018	CcSEcCtD
Ezogabine—Dermatitis—Citalopram—alcohol dependence	0.000338	0.0018	CcSEcCtD
Ezogabine—NAT2—Metabolism—ADH1A—alcohol dependence	0.000329	0.00197	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—ADH1B—alcohol dependence	0.000327	0.00196	CbGpPWpGaD
Ezogabine—Nausea—Citalopram—alcohol dependence	0.000319	0.0017	CcSEcCtD
Ezogabine—UGT1A3—Biological oxidations—GGT1—alcohol dependence	0.000317	0.0019	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—ALDH2—alcohol dependence	0.000299	0.00179	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—ALDH2—alcohol dependence	0.000299	0.00179	CbGpPWpGaD
Ezogabine—UGT1A1—NRF2 pathway—SLC6A4—alcohol dependence	0.000298	0.00179	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—SLC6A4—alcohol dependence	0.000298	0.00179	CbGpPWpGaD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000285	0.00171	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—MAOA—alcohol dependence	0.000284	0.00171	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ADH4—alcohol dependence	0.000279	0.00168	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—GRIN2B—alcohol dependence	0.000274	0.00165	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—GRIN2B—alcohol dependence	0.000274	0.00165	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—MAOB—alcohol dependence	0.000271	0.00162	CbGpPWpGaD
Ezogabine—UGT1A1—NRF2 pathway—SLC6A3—alcohol dependence	0.000265	0.00159	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—SLC6A3—alcohol dependence	0.000265	0.00159	CbGpPWpGaD
Ezogabine—UGT1A1—NRF2 pathway—GGT1—alcohol dependence	0.00025	0.0015	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—GGT1—alcohol dependence	0.00025	0.0015	CbGpPWpGaD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000244	0.00146	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000244	0.00146	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ADH6—alcohol dependence	0.00024	0.00144	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—CYP2E1—alcohol dependence	0.000239	0.00143	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—CYP2E1—alcohol dependence	0.000239	0.00143	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ADH7—alcohol dependence	0.000238	0.00143	CbGpPWpGaD
Ezogabine—UGT1A1—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000235	0.00141	CbGpPWpGaD
Ezogabine—UGT1A9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000235	0.00141	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—ALDH2—alcohol dependence	0.00023	0.00138	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—SLC6A4—alcohol dependence	0.000229	0.00138	CbGpPWpGaD
Ezogabine—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000229	0.00137	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GGT2—alcohol dependence	0.000228	0.00137	CbGpPWpGaD
Ezogabine—UGT1A4—Biological oxidations—POMC—alcohol dependence	0.000223	0.00134	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—GGT1—alcohol dependence	0.000219	0.00132	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—GGT1—alcohol dependence	0.000219	0.00132	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ADH1B—alcohol dependence	0.000208	0.00125	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—SLC6A3—alcohol dependence	0.000204	0.00123	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ADH6—alcohol dependence	0.0002	0.0012	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ADH1A—alcohol dependence	0.000199	0.00119	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—MAOA—alcohol dependence	0.000196	0.00118	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—MAOA—alcohol dependence	0.000196	0.00118	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—GGT1—alcohol dependence	0.000193	0.00116	CbGpPWpGaD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000186	0.00111	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—POMC—alcohol dependence	0.000185	0.00111	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—CYP2E1—alcohol dependence	0.000184	0.0011	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—MAOB—alcohol dependence	0.000173	0.00104	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ADH4—alcohol dependence	0.000169	0.00102	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—GGT1—alcohol dependence	0.000169	0.00101	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ADH1A—alcohol dependence	0.000165	0.000993	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—MAOA—alcohol dependence	0.000151	0.000909	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ALDH2—alcohol dependence	0.000147	0.000881	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ADH7—alcohol dependence	0.000144	0.000864	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ADH4—alcohol dependence	0.000141	0.000844	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ADH6—alcohol dependence	0.000138	0.000828	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GGT2—alcohol dependence	0.000138	0.000828	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ADH6—alcohol dependence	0.000138	0.000828	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—POMC—alcohol dependence	0.000128	0.000767	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—POMC—alcohol dependence	0.000128	0.000767	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ADH1B—alcohol dependence	0.000126	0.000757	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GOT2—alcohol dependence	0.000125	0.000749	CbGpPWpGaD
Ezogabine—UGT1A9—PPARA activates gene expression—EP300—alcohol dependence	0.000121	0.000728	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ADH7—alcohol dependence	0.00012	0.000718	CbGpPWpGaD
Ezogabine—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—alcohol dependence	0.000119	0.000712	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CYP2E1—alcohol dependence	0.000117	0.000704	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GGT2—alcohol dependence	0.000115	0.000688	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ADH1A—alcohol dependence	0.000114	0.000686	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ADH1A—alcohol dependence	0.000114	0.000686	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GGT1—alcohol dependence	0.000108	0.000646	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GOT1—alcohol dependence	0.000108	0.000646	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ADH6—alcohol dependence	0.000106	0.000638	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ADH1B—alcohol dependence	0.000105	0.00063	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—MAOB—alcohol dependence	0.000105	0.000628	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—POMC—alcohol dependence	9.86e-05	0.000592	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—EP300—alcohol dependence	9.86e-05	0.000591	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—EP300—alcohol dependence	9.86e-05	0.000591	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ADH4—alcohol dependence	9.72e-05	0.000583	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ADH4—alcohol dependence	9.72e-05	0.000583	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—MAOA—alcohol dependence	9.65e-05	0.000579	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ALDH2—alcohol dependence	8.89e-05	0.000534	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ADH1A—alcohol dependence	8.81e-05	0.000529	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—MAOB—alcohol dependence	8.69e-05	0.000522	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	8.42e-05	0.000505	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ADH7—alcohol dependence	8.27e-05	0.000496	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ADH7—alcohol dependence	8.27e-05	0.000496	CbGpPWpGaD
Ezogabine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—alcohol dependence	8.18e-05	0.000491	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GGT2—alcohol dependence	7.93e-05	0.000476	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GGT2—alcohol dependence	7.93e-05	0.000476	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GOT2—alcohol dependence	7.56e-05	0.000454	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ADH4—alcohol dependence	7.49e-05	0.00045	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALDH2—alcohol dependence	7.39e-05	0.000444	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ADH1B—alcohol dependence	7.25e-05	0.000435	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ADH1B—alcohol dependence	7.25e-05	0.000435	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP2E1—alcohol dependence	7.11e-05	0.000427	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GGT1—alcohol dependence	6.53e-05	0.000392	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GOT1—alcohol dependence	6.53e-05	0.000392	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ADH7—alcohol dependence	6.37e-05	0.000382	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GOT2—alcohol dependence	6.28e-05	0.000377	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—POMC—alcohol dependence	6.28e-05	0.000377	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GGT2—alcohol dependence	6.11e-05	0.000367	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MAOB—alcohol dependence	6.01e-05	0.00036	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—MAOB—alcohol dependence	6.01e-05	0.00036	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP2E1—alcohol dependence	5.91e-05	0.000355	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—MAOA—alcohol dependence	5.85e-05	0.000351	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ADH1B—alcohol dependence	5.59e-05	0.000335	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GGT1—alcohol dependence	5.43e-05	0.000326	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GOT1—alcohol dependence	5.43e-05	0.000326	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALDH2—alcohol dependence	5.11e-05	0.000306	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALDH2—alcohol dependence	5.11e-05	0.000306	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.91e-05	0.000295	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—MAOA—alcohol dependence	4.86e-05	0.000292	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MAOB—alcohol dependence	4.63e-05	0.000278	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GOT2—alcohol dependence	4.34e-05	0.000261	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GOT2—alcohol dependence	4.34e-05	0.000261	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—EP300—alcohol dependence	4.17e-05	0.00025	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP2E1—alcohol dependence	4.08e-05	0.000245	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP2E1—alcohol dependence	4.08e-05	0.000245	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALDH2—alcohol dependence	3.94e-05	0.000236	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—POMC—alcohol dependence	3.81e-05	0.000229	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GOT1—alcohol dependence	3.75e-05	0.000225	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GGT1—alcohol dependence	3.75e-05	0.000225	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GGT1—alcohol dependence	3.75e-05	0.000225	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GOT1—alcohol dependence	3.75e-05	0.000225	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—MAOA—alcohol dependence	3.36e-05	0.000202	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MAOA—alcohol dependence	3.36e-05	0.000202	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GOT2—alcohol dependence	3.35e-05	0.000201	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.26e-05	0.000195	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—POMC—alcohol dependence	3.17e-05	0.00019	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP2E1—alcohol dependence	3.15e-05	0.000189	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GOT1—alcohol dependence	2.89e-05	0.000173	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GGT1—alcohol dependence	2.89e-05	0.000173	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MAOA—alcohol dependence	2.59e-05	0.000155	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—EP300—alcohol dependence	2.53e-05	0.000152	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—POMC—alcohol dependence	2.19e-05	0.000131	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—POMC—alcohol dependence	2.19e-05	0.000131	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—EP300—alcohol dependence	2.1e-05	0.000126	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—POMC—alcohol dependence	1.69e-05	0.000101	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—EP300—alcohol dependence	1.45e-05	8.71e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—EP300—alcohol dependence	1.45e-05	8.71e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—EP300—alcohol dependence	1.12e-05	6.71e-05	CbGpPWpGaD
